| Bradley Allen Green, CRNA, MS | |
|
2333 Biddle Ave, Wyandotte, MI 48192-4668 | |
| (734) 246-6000 | |
| Not Available |
| Full Name | Bradley Allen Green |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 2333 Biddle Ave, Wyandotte, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538595079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704265869 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sjmhs Anesthesia Services | 7416053483 | 99 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
The food and beverages available to youth when they participate in organized sports can often be unhealthy, according to a new study released in the July/August 2012 issue of the Journal of Nutrition Education and Behavior.
Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.
In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.
› Verified 6 days ago
| Entity Name | Northern Anesthesia Providers Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396834628 PECOS PAC ID: 4789579863 Enrollment ID: O20040218000105 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
The food and beverages available to youth when they participate in organized sports can often be unhealthy, according to a new study released in the July/August 2012 issue of the Journal of Nutrition Education and Behavior.
Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.
In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.
› Verified 6 days ago
| Entity Name | Sjmhs Anesthesia Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215026281 PECOS PAC ID: 7416053483 Enrollment ID: O20070508000487 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
The food and beverages available to youth when they participate in organized sports can often be unhealthy, according to a new study released in the July/August 2012 issue of the Journal of Nutrition Education and Behavior.
Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.
In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.
› Verified 6 days ago
| Entity Name | Sleepsmith Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114463379 PECOS PAC ID: 8325320369 Enrollment ID: O20170126001573 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
The food and beverages available to youth when they participate in organized sports can often be unhealthy, according to a new study released in the July/August 2012 issue of the Journal of Nutrition Education and Behavior.
Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.
In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradley Allen Green, CRNA, MS 9261 Fox Ave, Allen Park, MI 48101-1507 Ph: () - | Bradley Allen Green, CRNA, MS 2333 Biddle Ave, Wyandotte, MI 48192-4668 Ph: (734) 246-6000 |
News Archive
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).
The food and beverages available to youth when they participate in organized sports can often be unhealthy, according to a new study released in the July/August 2012 issue of the Journal of Nutrition Education and Behavior.
Pregnant women exposed to persistent organic pollutants, or POPs, had slightly smaller fetuses than women who haven't been exposed to these chemicals, according to an analysis of ultrasound scans by researchers at the National Institutes of Health and other institutions.
In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).
Mark Bear, Picower Professor of Neuroscience at MIT, recalls the "eureka moment" 20 years ago when he realized that a severe developmental brain disorder -;fragile X syndrome-;might be treated with drugs that inhibit a neurotransmitter receptor called mGluR5.
› Verified 6 days ago
Kurt M Schuon, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2333 Biddle St, Wyandotte, MI 48192 Phone: 734-324-3697 Fax: 734-324-3425 | |
Charles T Carpenter, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2333 Biddle St, Wyandotte, MI 48192 Phone: 734-324-3697 Fax: 734-324-3425 | |
Jessica Finateri, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2333 Biddle Ave, Wyandotte, MI 48192 Phone: 734-246-6000 | |
Mrs. Janis Faye Grose, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 70 Poplar St, Wyandotte, MI 48192 Phone: 734-285-7198 | |
Jamie Ettaher, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2333 Biddle Ave, Wyandotte, MI 48192 Phone: 734-246-6000 | |
Jayne A Cady, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2333 Biddle St, Wyandotte, MI 48192 Phone: 734-324-3697 Fax: 734-324-3425 | |
Evan R Guffey, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2085 17th St, Wyandotte, MI 48192 Phone: 734-775-5758 |